# Enhanced Medication Reconciliation For Serious Mental Illness

> **NCT03169868** · NA · TERMINATED · sponsor: **Precera Bioscience, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Mental Disorders

## Interventions

- **DIAGNOSTIC_TEST:** Sano Patient Medication Profile

## Key facts

- **NCT ID:** NCT03169868
- **Lead sponsor:** Precera Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-27
- **Primary completion:** 2019-01-21
- **Final completion:** 2019-01-21
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Enrollment rate insufficient to fully enroll study within the planned timeline.
- **Last updated:** 2019-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169868, "Enhanced Medication Reconciliation For Serious Mental Illness". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03169868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*